New therapeutics to add

[rando2]

Two new therapeutics that should be added to the pharmaceuticals manuscript:

• MAb from AstraZeneca: https://www.astrazeneca.com/media-centre/press-releases/2021/azd7442-prophylaxis-trial-met-primary-endpoint.html
• Antiviral from Merck: https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/

[agitter]

• PAXLOVID: https://www.nature.com/articles/d41586-021-03074-5
• Fluvoxamine: https://www.science.org/content/blog-post/fluvoxamine-coronavirus